Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 6, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	31,647	56,595	59,667	28,552	14,022	4,643
Market Cap Growth	-20.54%	-5.15%	108.98%	103.62%	201.99%	12.92%
Enterprise Value	41,470	62,791	63,025	30,523	15,593	6,005
Last Close Price	137.00	243.40	255.07	121.28	59.05	19.21
PE Ratio	67.91	110.28	63.01	32.46	35.83	37.69
PS Ratio	3.20	6.65	7.44	4.01	2.51	1.00
PB Ratio	5.17	9.52	10.04	5.33	3.03	1.56
P/FCF Ratio	-13.33	-47.43	-93.66	-244.34	-615.02	-200.46
P/OCF Ratio	-29.26	91.11	55.14	145.26	48.16	21.06
EV/Sales Ratio	4.19	7.38	7.86	4.29	2.79	1.29
EV/EBITDA Ratio	21.57	42.24	30.64	17.47	18.46	6.96
EV/EBIT Ratio	30.84	64.89	38.97	22.41	46.76	19.10
EV/FCF Ratio	-11.65	-52.63	-98.93	-261.21	-683.92	-259.26
Debt / Equity Ratio	1.65	1.25	0.64	0.47	0.47	0.60
Debt / EBITDA Ratio	5.26	5.01	1.86	1.43	2.58	2.07
Debt / FCF Ratio	-2.84	-6.25	-6.01	-21.37	-95.68	-77.06
Asset Turnover	0.62	0.67	0.83	0.91	0.93	0.95
Inventory Turnover	2.36	2.14	2.40	2.99	2.67	2.34
Quick Ratio	0.38	0.34	0.54	0.82	0.90	0.76
Current Ratio	1.35	1.15	1.38	1.87	1.84	2.03
Return on Equity (ROE)	7.59%	8.58%	16.55%	17.29%	10.01%	3.94%
Return on Assets (ROA)	5.24%	4.75%	10.45%	10.83%	3.46%	4.02%
Return on Capital (ROIC)	5.82%	5.22%	11.47%	11.61%	3.60%	4.12%
Earnings Yield	1.47%	0.90%	1.57%	3.02%	2.72%	2.53%
FCF Yield	-11.25%	-2.11%	-1.07%	-0.41%	-0.16%	-0.50%
Dividend Yield	1.17%	0.66%	0.63%	1.24%	-	2.60%
Payout Ratio	77.61%	72.78%	39.95%	6.88%	15.23%	100.30%
Total Shareholder Return	1.17%	0.66%	0.63%	1.24%	-	2.60%

Source: S&P Capital IQ. Standard template. Financial Sources.